LONDONAfter laying out the case for going it alone AstraZeneca PLC executives have hit the road in Europe to win over investors who could play a crucial role in determining whether Pfizer Incs  billion unsolicited bid for the British drug maker goes ahead  AstraZeneca laid out ambitious sales goals earlier this week after rejecting that bid of   a share from the US company saying it significantly undervalued the company Pfizer meanwhile is weighing its options but so far has been mum on whether it
  